As the world continues to advance technologically, there has been a growing concern about the impact of Artificial Intelligence (AI) on society. This concern is particularly relevant in third-world countries like Zimbabwe, where many people are already struggling to make ends meet. It is important to understand what AI is and how it works. AI refers to the development of computer systems that can perform tasks that would normally require human intelligence, such as learning, problem-solving, and decision-making. These systems use algorithms and data to analyze information and make predictions or recommendations based on that analysis. One of the main concerns about AI is that it could lead to job losses as machines replace human workers.

The discussion of Artificial Intelligence (AI) has become so prevalent that every sector is now informed of its existence. Over the years, technology has been a major driving force in growing and developing human work states and engagements. With various examples of newly developed AI, the adoption of this digital revolution has become so paramount to everyone. However, an important question I have amid all these is, "how will AI help developing Third World countries?" It is important to first examine what third-world countries are before delving into the ways in which AI can help them better.

WITH the cost of bringing a new drug to market now an average US$2.6bn1 and one-in-ten drug candidates failing to make it to market despite successfully completing Phase I trials2, it is no wonder that pharmaceutical companies have seized on the unparalleled data-processing potential of artificial intelligence (AI) systems. Their use in identifying compounds, some of which may have completed clinical trials already, that could be re-purposed to treat alternative diseases quickly and comparatively cheaply, is well documented. But as research scientists are beginning to find, AI systems are capable of achieving so much more. The potential applications of AI in drug discovery are almost endless, but one of the main areas of focus to date has been repurposing existing drugs. Typically, this involves finding new uses for drugs that have already attained market and regulatory approvals for the treatment of a specific disease.